These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Pretransplant antibodies and renal allograft survival. MacLeod AM; Mason RJ; Power DA; Edward N; Stewart KN; Shewan G; Catto GR Proc Eur Dial Transplant Assoc; 1983; 20():305-8. PubMed ID: 6361743 [TBL] [Abstract][Full Text] [Related]
9. B cell positive cross-match not due to anti-HLA Class I antibodies and first kidney graft outcome. Praticò-Barbato L; Conca R; Magistroni P; Leonardi G; Oda A; Rosati F; Leone E; Tacconella M; Roggero S; Segoloni GP; Amoroso A Transpl Immunol; 2008 Jul; 19(3-4):238-43. PubMed ID: 18675725 [TBL] [Abstract][Full Text] [Related]
10. Relevance of posttransplant flow cytometric T- and B-cell crossmatches in tacrolimus-treated renal transplant patients. Lenaers JI; Christiaans MH; Voorter CE; van Hooff HP; van den Berg-Loonen EM Transplantation; 2006 Nov; 82(9):1142-7. PubMed ID: 17102764 [TBL] [Abstract][Full Text] [Related]
11. Identification of the antibodies involved in B-cell crossmatch positivity in renal transplantation. Le Bas-Bernardet S; Hourmant M; Valentin N; Paitier C; Giral-Classe M; Curry S; Follea G; Soulillou JP; Bignon JD Transplantation; 2003 Feb; 75(4):477-82. PubMed ID: 12605113 [TBL] [Abstract][Full Text] [Related]
12. Flow cytometry crossmatching and primary cadaver kidney graft outcome: relevance of T and B cell targets, historic sera and autologous controls. LeFor WM; Ackermann JR; Alveranga DY; Bowers VD; Heinrichs DF; Kahana L; Shires DL; Weinstein SS; Wright CE Clin Transplant; 1996 Dec; 10(6 Pt 2):601-6. PubMed ID: 8996750 [TBL] [Abstract][Full Text] [Related]
14. [Immunological analysis of mixed lymphocyte culture reaction inhibitory factor induced by donor specific blood transfusions in potential kidney transplant patients]. Takeuchi H Nihon Geka Gakkai Zasshi; 1985 Mar; 86(3):339-49. PubMed ID: 3157045 [TBL] [Abstract][Full Text] [Related]
15. Good kidney transplant outcome in recipients with presensitization against HLA class II but not HLA class I. Süsal C; Opelz G Hum Immunol; 2004 Aug; 65(8):810-6. PubMed ID: 15336782 [TBL] [Abstract][Full Text] [Related]
16. Renal graft survival is not influenced by a positive flow B-cell crossmatch. Bryan CF; Wakefield M; Reese JC; Shield CF; Warady BA; Winklhofer FT; Murillo D Clin Transplant; 2007; 21(1):72-9. PubMed ID: 17302594 [TBL] [Abstract][Full Text] [Related]
17. Association of anti-Fab and anti-IgG antibodies with high kidney transplant survival. Chia D; Horimi T; Terasaki PI; Hermes M Transplant Proc; 1982 Jun; 14(2):322-4. PubMed ID: 7051474 [TBL] [Abstract][Full Text] [Related]
18. The LifeLink Foundation and cadaver kidney transplantation in Tampa. LeFor WM; Wright CE; Bowers VD; Heinrichs DF; Shires DL Clin Transpl; 1999; ():149-58. PubMed ID: 11038633 [TBL] [Abstract][Full Text] [Related]
19. Patient and graft survival of kidney allograft recipients with minimal hepatitis C virus infection: a case-control study. Shahbazian H; Hajiani E; Ehsanpour A Urol J; 2008; 5(3):178-83. PubMed ID: 18825625 [TBL] [Abstract][Full Text] [Related]
20. IgG donor-specific crossmatches are not associated with graft rejection or poor graft survival after liver transplantation. An assessment by cytotoxicity and flow cytometry. Donaldson PT; Thomson LJ; Heads A; Underhill JA; Vaughan RW; Rolando N; Williams R Transplantation; 1995 Nov; 60(9):1016-23. PubMed ID: 7491675 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]